Today, the Community Oncology Alliance (COA) Board of Directors released a position statement supporting the use of telehealth as a valuable supplement to in-person visits during the COVID-19 (novel coronavirus) pandemic and continued usage when appropriate after the pandemic has subsided. The COVID-19 pandemic has spurred the rapid adoption of telehealth by oncology providers. The

Today, the U.S. Department of Health and Human Services and the U.S. Food and Drug Administration took actions to help provide safe, effective, and more affordable drugs to American patients as part of the Safe Importation Action Plan, fulfilling the aspect of the July Executive Order on drug pricing to complete the rulemaking to allow

People with cancer are at increased risk for severe COVID-19. Now, a preliminary study suggests that certain cancer therapies may heighten those odds even further. Researchers found that of 3,600 U.S. cancer patients who contracted COVID-19, the highest risk of death was among those who'd received cancer treatment within the past three months. And the

Patients with BRCA1/2 mutations are at higher risk for breast, ovarian and prostate cancers that can be aggressive when they develop – and, in many cases, resistant to lifesaving drugs. Now scientists at The University of Texas at Austin and Ajou University in South Korea have identified a driver of the drug resistance that can

The American Association for Cancer Research published its first progress report on cancer disparities, outlining the complex reasons why they exist and a plan for how the country can overcome them. The report comes at a crucial time during the coronavirus pandemic, when federal officials and institutions are thinking more criticallyabout racial disparities in health care. Read the

When Caiti Derenze, a lawyer in Jersey City, N.J., went to Walgreens to refill her insulin prescription in July, she was met with a nearly $300 bill. “I was like, ‘Oh my God, I only paid like $50 last month. What happened?’” Ms. Derenze said. “It feels like a punch in the gut, to be

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. COVID-19 may damage immune cells in the bone marrow Even bone marrow may not be a safe harbor from the ravages of COVID-19, according

Scientists at Fred Hutchinson Cancer Research Center believe they’ve found a better of use of mobile technology to help adult cigarette smokers quit. In a large clinical trial published in JAMA Internal Medicine, a team led by Dr. Jonathan Bricker, a professor in Fred Hutch’s Public Health Sciences Division, tested the efficacy of the new

Human papillomavirus (HPV)-mediated squamous cell carcinoma of the head and neck is on the rise, and the lack of herd immunity in young people will ensure growth for many years to come. "We're really looking at another 30 to 40 years of HPV and oropharynx cancer growth," said head and neck cancer surgeon Joseph Califano,

An international survey provides new insights into how COVID-19 has affected, and may continue to affect, the field of oncology. The survey showed that "COVID-19 has had a major impact on the organization of patient care, on the well-being of caregivers, on continued medical education, and on clinical trial activities in oncology," stated Guy Jerusalem, MD,